Maral DerSarkissian

Vice President
Maral DerSarkissian

Los Angeles


Ph.D., epidemiology, University of California, Los Angeles; B.A., public health, University of California, Berkeley

Summary of Experience

Dr. DerSarkissian’s expertise includes epidemiologic methodology and applications of modern methods to observational health data. She has a wide range of experience in pharmacoepidemiology, biostatistics, and health economics and outcomes research, including studies on causal methods. Dr. DerSarkissian has conducted cost-effectiveness and comparative effectiveness studies; examined treatment patterns, drug adherence, health care resource utilization and costs, and clinical outcomes; assessed direct medical and indirect productivity costs of a disease burden; assessed patient-reported quality of life and the humanistic burden of a disease; and worked on Food and Drug Administration (FDA) post-marketing authorization safety studies. She has used data from electronic medical records, clinical trials, commercial insurance claims, patient surveys, and medical chart review studies in disease areas that include obesity; HIV/AIDS; cardiovascular diseases; schizophrenia; autoimmune, neurologic, and rare hereditary disorders; and many types of cancer. Dr. DerSarkissian has provided regulatory and strategic consulting on drug and medical device registration and real-world evidence generation for regulatory submissions, such as new drug applications (NDAs) and supplemental new drug applications (sNDAs). She has also conducted real-world evidence studies to contextualize the results of clinical trials in support of NDA and sNDA submissions. She has presented her research at conferences on epidemiology and health services, and published articles in a number of peer-reviewed journals. Dr. DerSarkissian is an adjunct assistant professor in the epidemiology department at the UCLA Fielding School of Public Health.

Read Maral's profile 

Selected Publishing